• OPEN AN ACCOUNT
Indian Indices
Sensex
72,529.07 -242.65
( -0.33%)
Global Indices
Nasdaq
51,510.98 -338.64
(-0.65%)
Dow Jones
7,705.40 -59.01
(-0.76%)
Hang Seng
65,155.57 -722.05
(-1.10%)
Nikkei 225
10,628.22 -56.66
(-0.53%)
Forex
USD-INR
95.79 -0.10
(-0.10%)
EUR-INR
109.09 0.01
(0.01%)
GBP-INR
126.83 0.01
(0.01%)
JPY-INR
0.61 0.00
(0.68%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
16.63
14832.09
EPS(TTM)
Face Value()
Div & Yield %
49.8
2
0.6
 

Gillanders Arbuthnot & Company reports consolidated net loss of Rs 3.89 crore in the March 2026 quarter
May 11,2026
Net loss of Gillanders Arbuthnot & Company reported to Rs 3.89 crore in the quarter ended March 2026 as against net profit of Rs 2.04 crore during the previous quarter ended March 2025. Sales declined 0.53% to Rs 103.39 crore in the quarter ended March 2026 as against Rs 103.94 crore during the previous quarter ended March 2025.

For the full year,net profit declined 64.56% to Rs 9.47 crore in the year ended March 2026 as against Rs 26.72 crore during the previous year ended March 2025. Sales declined 2.78% to Rs 430.87 crore in the year ended March 2026 as against Rs 443.18 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales103.39103.94 -1 430.87443.18 -3
OPM %-4.22-2.00 -5.425.80 -
PBDT-2.13-1.11 -92 22.0023.89 -8
PBT-4.92-3.71 -33 11.0813.03 -15
NP-3.892.04 PL 9.4726.72 -65